Max Robotics — Global Service Robot Directory + US Certification

About

Caroline Dial is a pioneering biomedical researcher whose work centers on advancing drug delivery systems to improve the bioavailability of macromolecules—a critical challenge in pharmaceutical science. Her most notable contribution, detailed in her 2025 paper "Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining," introduces a novel, in situ-forming synthetic barrier that temporarily modulates epithelial permeability. This breakthrough approach, demonstrated in both rodent and porcine models, offers a non-invasive strategy to enhance the absorption of large therapeutic agents, such as proteins and peptides, which are typically hindered by biological barriers. While currently early in its citation impact, this work represents a significant step toward oral or topical delivery of biologics, potentially reducing reliance on injections. Dial’s research bridges materials science and physiology, with implications for treating chronic diseases requiring macromolecule-based therapies. Her innovative methodology and translational focus mark her as an emerging leader in drug delivery, with future work poised to influence clinical practices and patient outcomes.